Lung-Function Response To Tiotropium plus Olodaterol In Patients With COPD With β-Agonist Reversibility

被引：0
|
作者：
Tashkin, D. P. [1 ]
Ferguson, G. T. [2 ]
Clerisme-Beaty, E. [3 ]
Vob, F. [4 ]
Buhl, R. [5 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Pulm Res Inst Southeast Michigan, Farmington Hills, MI USA
[3] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Mainz Univ Hosp, Dept Pulm, Mainz, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6808
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockers
    Derom, Eric
    Korn, Stephanie
    Hamilton, Alan
    Amatto, Valeria C.
    Zhao, Yihua
    Maltais, Francois
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [42] Efficacy of tiotropium/olodaterol on sedentary/active time in COPD patients: VESUTO study
    Minakata, Yoshiaki
    Motegi, Takashi
    Ueki, Jun
    Gon, Yasuhiro
    Seki, Tetsuo
    Anzai, Tatsuhiko
    Nakamura, Shuhei
    Hirata, Kazuto
    Ichinose, Masakazu
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [43] Improved medication adherence in COPD patients using tiotropium or tiotropium olodaterol with the HealthPrize digital behavior change program
    Firlik, Katrina S.
    Anupindi, Vamshi Ruthwik
    Hayes, Vincent
    DeKoven, Mitchell
    Shaikh, Asif
    Franchino-Elder, Jessica
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (07) : 829 - 843
  • [44] BENEFITS OF TIOTROPIUM/OLODATEROL OVER TIOTROPIUM AT DELAYING CLINICALLY SIGNIFICANT EVENTS IN PATIENTS WITH COPD CLASSIFIED AS GOLD B
    Buhl, R.
    McGarvey, L.
    Korn, S.
    Ferguson, G. T.
    Groenke, L.
    Hallmann, C.
    Voss, F.
    Rabe, K. F.
    Maltais, F.
    THORAX, 2016, 71 : A251 - A252
  • [45] Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
    Ramadan, Wijdan H.
    Kabbara, Wissam K.
    El Khoury, Ghada M.
    Al Assir, Sarah A.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 : 2347 - 2356
  • [46] Cost-Effectiveness Analysis of Fixed-Dose Tiotropium/Olodaterol versus Tiotropium for COPD Patients in China
    Lan, Ying
    Yang, Nan
    Wang, Yirong
    Yang, Yan
    Xu, Min
    He, Qin
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 18 : 2093 - 2103
  • [47] BENEFITS OF TIOTROPIUM/OLODATEROL OVER TIOTROPIUM AT DELAYING CLINICALLY SIGNIFICANT EVENTS IN PATIENTS WITH COPD CLASSIFIED AS GOLD B
    不详
    THORAX, 2016, 71 : A272 - A273
  • [48] Analysis Of The Efficacy And Safety Of The Fixed-Dose Combination Of Tiotropium plus Olodaterol In Patients With COPD By Previous Usage Of Inhaled Corticosteroids
    Korn, S.
    Buhl, R.
    Gronke, L.
    Korducki, L.
    Amatto, V. C.
    Ferguson, G. T.
    Abrahams, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [49] REVERSIBILITY OF LUNG-FUNCTION ABNORMALITIES IN CHILDREN WITH PERENNIAL ASTHMA
    KRAEMER, R
    MEISTER, B
    SCHAAD, UB
    ROSSI, E
    JOURNAL OF PEDIATRICS, 1983, 102 (03): : 347 - 350
  • [50] Systemic Manifestations of COPD and the Impact of Dual Bronchodilation with Tiotropium/Olodaterol on Cardiac Function and Autonomic Integrity
    Dimiene, Ieva
    Hoppenot, Deimante
    Vajauskas, Donatas
    Padervinskiene, Lina
    Rimkunas, Airidas
    Zemaitis, Marius
    Barkauskiene, Diana
    Lapinskas, Tomas
    Ereminiene, Egle
    Miliauskas, Skaidrius
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
12345